Most IVIG side effects are mild and short-lived, typically fading within a few hours to a day after the infusion ends. Headache, chills, fatigue, flushing, and low-grade fever are the most common complaints, and they rarely require anything beyond over-the-counter remedies or simply waiting them out. A small number of people, however, develop rarer complications that can take days or even weeks to fully resolve, so the honest answer depends heavily on which side effect you’re dealing with.
The Common, Mild Reactions
The side effects most people experience during or shortly after an IVIG infusion include headache, flushing, malaise, fever, chills, fatigue, and lethargy. These are considered transient and mild, and treatment is mainly supportive, meaning rest, fluids, and perhaps acetaminophen or ibuprofen.1PubMed Central. Adverse Effects of Immunoglobulin Therapy Most of these start during the infusion itself or within the first hour afterward and taper off within a few hours once the infusion is stopped or slowed. For many patients, by the next morning the worst has passed.
Headache deserves special mention because it’s one of the most frequent complaints and sometimes the most stubborn. While a mild infusion-day headache often resolves overnight, some people develop a more persistent headache that can linger for a day or two. In those cases, strategies like hydration, slower infusion rates, switching IVIG brands, or using medications such as oral analgesics, triptans, or propranolol before, during, or after the infusion have shown benefit, though the evidence behind specific approaches is limited to case reports and small studies.2PubMed. Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches
Aseptic Meningitis
One of the more alarming IVIG side effects is aseptic meningitis, an inflammation of the membranes surrounding the brain and spinal cord that is not caused by a bacterial infection. The word “meningitis” understandably frightens people, but the IVIG-induced version is not the same disease as bacterial meningitis and is not fatal. The onset varies widely: symptoms can appear within 24 hours of the first infusion or as late as 10 days after the last one.3PubMed Central. Intravenous Immunoglobulin-Induced Aseptic Meningitis—A Narrative Review of the Diagnostic Process, Pathogenesis, Preventative Measures and Treatment Symptoms include severe headache, neck stiffness, nausea, sensitivity to light, and sometimes fever.
The tricky part is that aseptic meningitis looks almost identical to bacterial meningitis when it first presents. Patients in one retrospective review typically showed up with symptoms within 24 to 48 hours of the IVIG infusion and were initially started on antibiotics because bacterial meningitis couldn’t immediately be ruled out. Once cultures came back negative and the clinical picture clarified, supportive care was all that was needed. Symptoms self-resolved within five to seven days.4Blood. Incidence and Natural History of Ivig-Induced Aseptic Meningitis: A Retrospective Review at a Single Tertiary Care Centre If you develop a severe headache with neck stiffness after IVIG, it’s important to be evaluated promptly so bacterial meningitis can be excluded, but the reassuring news is that the IVIG-related form clears up on its own within about a week.
Hemolytic Anemia
IVIG is pooled from thousands of blood donors, and the resulting product contains antibodies against blood group antigens, particularly anti-A and anti-B. In people with blood types A, B, or AB, these transferred antibodies can attack red blood cells and trigger hemolysis, the premature destruction of red blood cells. People with blood type O face a lower risk because they lack the A and B antigens on their red cells.5PubMed Central. Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
Hemolysis has been reported to begin anywhere from 12 hours to 10 days after the first IVIG infusion. Mild cases may involve a gradual drop in hemoglobin that the body compensates for on its own over a week or two. Severe cases can require blood transfusions or other interventions. The duration of the hemolytic episode depends on its severity: a mild dip in red blood cell counts resolves as the transferred antibodies are naturally cleared from the body, while a severe episode with significant anemia can take longer to recover from and needs close monitoring through blood work.
Kidney Problems
Acute kidney injury after IVIG is rare but has a potentially longer recovery timeline than the milder side effects. Kidney function usually bounces back within about 10 days.6Journal of Rheumatic Diseases. Aseptic Meningitis and Acute Kidney Injury after Immunoglobulin Infusion in a Patient with Systemic Lupus Erythematosus and Immune Thrombocytopenic Purpura In general, this type of kidney injury is reversible, though roughly 30% of cases are severe enough to require temporary dialysis.7PubMed Central. Severe Acute Kidney Injury Secondary to Immunoglobulin Infusion in Life-Threatening Guillain Barre Syndrome And in a small minority, renal function does not fully recover. One study of 119 patients found kidney impairment in about 7%, and in roughly 2% of patients, no renal recovery occurred at all.8QJM: An International Journal of Medicine. Nephrotoxicity of intravenous immunoglobulin
The risk is highest in people who are already dehydrated, have pre-existing kidney disease, diabetes, high blood pressure, or are older. Products stabilized with sucrose have been more strongly linked to kidney damage than sucrose-free formulations, because sucrose can cause osmotic injury to the kidney tubules.9PubMed. Safety of intravenous immunoglobulin (IVIG) therapy If you fall into a higher-risk category, your treatment team will likely check kidney labs before and after infusions and may choose a sucrose-free product specifically to lower this risk.
Blood Clots
IVIG temporarily increases the risk of thromboembolic events, meaning blood clots that can lodge in arteries or veins. The timing is sharply concentrated around the infusion itself. In one study of patients with blood cancers, the risk of an arterial clot was about three and a half times higher on the day of the infusion and the day after, compared to non-infusion periods. That elevated risk dropped steadily over the next two weeks and was essentially back to baseline by days 16 to 30.10PubMed Central. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy A separate study looking at hospitalized patients receiving IVIG for neurological conditions found similarly elevated odds of venous blood clots within 30 days of infusion.11PubMed. Risk of thrombotic events after inpatient intravenous immunoglobulin or plasma exchange for neurologic disease: A case-crossover study
The practical point is that the danger window is narrow. The first 48 hours after an infusion carry the most risk, and the risk tapers over the following weeks. If you have risk factors for blood clots, such as a history of deep vein thrombosis, recent surgery, immobility, or an underlying clotting disorder, your medical team should be aware before IVIG is administered. Staying well-hydrated and mobile after infusions are simple but meaningful precautions.
Transfusion-Related Acute Lung Injury
TRALI is one of the most serious possible reactions to any blood product, including IVIG. It causes sudden pulmonary edema (fluid in the lungs) that is not related to heart failure or fluid overload. It typically strikes fast, often during or within the first few hours of an infusion, with sudden fever, rapid heart rate, falling blood pressure, and worsening oxygen levels. A French multicenter study found that TRALI symptoms appeared either during the infusion or up to 24 hours afterward, and over half of affected patients needed mechanical ventilation, typically for about one day.12PubMed. Transfusion-related acute lung injury (TRALI) after intravenous immunoglobulins: French multicentre study and literature review
Recovery in survivors is often surprisingly quick given how dramatic the acute episode looks. In one case, a patient who developed TRALI during IVIG for a COVID-19-related illness was discharged just three days later with no lasting lung impairment.13PubMed Central. Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2 But TRALI can also be fatal: that same French review reported a 24% mortality rate among affected patients. This is a genuine emergency requiring intensive care, and its severity varies enormously from person to person. When it resolves, it tends to do so within days, but the unpredictability of outcomes makes it the side effect that physicians watch for most closely during infusions.
Why Side Effects Vary So Much Between People
The wide range of possible timelines partly comes down to the IVIG products themselves and partly to who’s receiving them. Not all IVIG formulations are identical. They differ in concentration, volume, osmolality, sodium content, and sugar content, and these differences affect tolerability.14PubMed. Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy A person who has recurring side effects on one brand may do much better after switching to another.
Individual risk factors matter just as much. Pre-existing kidney disease, dehydration, diabetes, advanced age, and high blood pressure all increase the chance of serious complications. People with IgA deficiency are sometimes flagged for heightened anaphylaxis risk, though the relationship between anti-IgA antibodies and severe reactions has been debated for years. In one long-term observational study, patients with anti-IgA antibodies experienced only mild symptoms such as headache, fatigue, and malaise during and after infusions.15PubMed Central. Association of anti-IgA antibodies with adverse reactions to gamma globulin infusion The rarity of true anaphylaxis makes it difficult to study, but when it does occur, it typically happens during the infusion itself and resolves within minutes to hours with appropriate emergency treatment.
What You Can Do to Reduce Side Effects
Several strategies can shorten or prevent side effects altogether. The most well-supported approaches include slowing the infusion rate, premedication, and adequate hydration.
- Slower rates: Many side effects are rate-dependent. Starting slowly and increasing the rate in steps gives the body more time to adjust to the large protein load.
- Hydration: Drinking plenty of fluids before, during, and after infusions helps protect the kidneys and may reduce headaches. In high-risk patients, intravenous fluids before the infusion are often used alongside a slow rate and low product concentration.16PubMed. Intravenous immunoglobulin: adverse effects and safe administration
- Premedication: Acetaminophen, diphenhydramine, or a small dose of corticosteroid given before the infusion can blunt the inflammatory response that causes fever, chills, and headache.
- Product switching: If one formulation consistently causes problems, trying a different manufacturer’s product with a different stabilizer, concentration, or osmolality can help.
- Subcutaneous route: For people who need long-term immunoglobulin replacement, switching from intravenous to subcutaneous delivery is an option. Subcutaneous immunoglobulin tends to produce fewer systemic side effects because the dose enters the bloodstream gradually rather than all at once.1PubMed Central. Adverse Effects of Immunoglobulin Therapy
These measures don’t eliminate risk entirely, but they meaningfully reduce both the frequency and severity of reactions for most patients.
False-Positive Lab Tests After IVIG
This isn’t a “side effect” in the way most people think of one, but it can cause real confusion and unnecessary treatment. Because IVIG is pooled from thousands of donors, it contains antibodies against a huge variety of infections those donors have been exposed to over their lifetimes. After an infusion, those borrowed antibodies show up on your blood tests as though they’re your own, potentially triggering false-positive results for diseases you’ve never had.
In a prospective study of seven patients, each one developed new positive antibody results after IVIG, with two to five new false detections per person. These included false positives for Epstein-Barr virus, herpes simplex, West Nile virus, cytomegalovirus, and fungal infections like histoplasmosis and coccidioidomycosis.17PubMed. Impact of IVIG therapy on serologic testing for infectious diseases The number of false positives appeared to follow a dose-response pattern, meaning higher IVIG doses produced more spurious results.
These false positives can persist for days to weeks after the infusion, varying with the natural half-life of the infused IgG antibodies.18PubMed Central. Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report The half-life of IgG in the body is roughly three to four weeks, so serologic tests performed in that window should be interpreted with caution. If you need bloodwork for an infection shortly after IVIG, make sure the ordering physician knows about your recent infusion. Otherwise, you could end up treated for a disease you don’t actually have.
Do Side Effects Get Better or Worse Over Time?
People who receive IVIG on a recurring schedule, sometimes monthly for years, often wonder whether their body adapts or whether cumulative exposure makes things worse. The answer is mixed and not well studied in large trials. Anecdotally, many patients and their treating physicians report that side effects are worst during the first few infusions and improve as the body adjusts. The first infusion is often the roughest because the immune system has never encountered such a large bolus of foreign IgG before.
On the other hand, some complications are idiosyncratic and can appear for the first time after months or years of uneventful treatment. Aseptic meningitis, for instance, has been reported in patients who had previously tolerated many infusion cycles without trouble. Serious adverse effects are associated with specific immunoglobulin preparations and individual differences rather than simply cumulative dose.1PubMed Central. Adverse Effects of Immunoglobulin Therapy A change in manufacturer or lot can sometimes trigger a reaction in someone who was fine before, because the antibody composition varies between batches.
For patients who do develop a new or worsening side effect after a track record of tolerating IVIG well, the usual approach is premedication for subsequent infusions or a switch to a different formulation. In some cases, switching from intravenous to subcutaneous delivery resolves the problem entirely.
When to Seek Medical Attention
Given the wide range of possible side effects and timelines, knowing when to call your doctor versus when to ride it out is genuinely useful. Mild symptoms like a low-grade fever, a dull headache, or general fatigue on infusion day are expected and manageable at home. If a headache is moderate and persisting into the next day but responding to over-the-counter pain relievers, that’s still generally within the normal range.
Seek prompt medical evaluation if you develop any of the following within the first two weeks after an infusion:
- Severe headache with neck stiffness: This combination raises the possibility of aseptic meningitis and needs to be distinguished from bacterial meningitis.
- Dark or tea-colored urine: A sign that red blood cells are being destroyed, which could indicate hemolytic anemia.
- Markedly decreased urine output: Along with swelling or sudden weight gain, this could signal kidney injury.
- Sudden shortness of breath or chest pain: Could indicate TRALI or a thromboembolic event, both of which require emergency care.
- Leg swelling or sudden calf pain: Possible signs of a deep vein thrombosis.
None of these complications are common, but they’re the ones where early recognition meaningfully changes outcomes. Most people who receive IVIG will experience nothing worse than a rough evening after infusion day, and even that tends to become more predictable and manageable with experience and the right preventive measures.